{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:00:22Z","timestamp":1783490422689,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007261","name":"New York Academy of Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007261","id-type":"DOI","asserted-by":"crossref"}]},{"name":"abiomed"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-021-10121-w","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:28:48Z","timestamp":1620775728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Theoretical considerations for a left atrial pump in heart failure with preserved ejection fraction"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-4631","authenticated-orcid":false,"given":"Hannah","family":"Rosenblum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"10121_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A et al (2019) Heart Disease and Stroke Statistics-2019 Update: a report from the American Heart Association. Circulation 139:e56\u2013e528","journal-title":"Circulation"},{"key":"10121_CR2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.amjcard.2007.11.061","volume":"101","author":"LR Loehr","year":"2008","unstructured":"Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE (2008) Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101:1016\u20131022","journal-title":"Am J Cardiol"},{"key":"10121_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251\u2013259","journal-title":"N Engl J Med"},{"key":"10121_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","volume":"10","author":"AA Oktay","year":"2013","unstructured":"Oktay AA, Rich JD, Shah SJ (2013) The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep 10:401\u2013410","journal-title":"Curr Heart Fail Rep"},{"key":"10121_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/CIRCULATIONAHA.117.027551","volume":"138","author":"PP Chang","year":"2018","unstructured":"Chang PP, Wruck LM, Shahar E et al (2018) Trends in hospitalizations and survival of acute decompensated heart failure in four us communities (2005\u20132014): ARIC Study Community Surveillance. Circulation 138:12\u201324","journal-title":"Circulation"},{"key":"10121_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","volume":"11","author":"MS Maurer","year":"2005","unstructured":"Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D (2005) Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 11:177\u2013187","journal-title":"J Card Fail"},{"key":"10121_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","volume":"134","author":"SJ Shah","year":"2016","unstructured":"Shah SJ, Kitzman DW, Borlaug BA et al (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 134:73\u201390","journal-title":"Circulation"},{"key":"10121_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","volume":"4","author":"M Haass","year":"2011","unstructured":"Haass M, Kitzman DW, Anand IS et al (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 4:324\u2013331","journal-title":"Circ Heart Fail"},{"key":"10121_CR9","doi-asserted-by":"publisher","first-page":"e006414","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","volume":"13","author":"MS Sabbah","year":"2020","unstructured":"Sabbah MS, Fayyaz AU, de Denus S et al (2020) Obese-inflammatory phenotypes in heart failure with preserved ejection fraction. Circ Heart Fail 13:e006414","journal-title":"Circ Heart Fail"},{"key":"10121_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","volume":"106","author":"\u00c5K Hedman","year":"2020","unstructured":"Hedman \u00c5K, Hage C, Sharma A et al (2020) Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart 106:342","journal-title":"Heart"},{"key":"10121_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11936-019-0709-4","volume":"21","author":"DN Silverman","year":"2019","unstructured":"Silverman DN, Shah SJ (2019) Treatment of heart failure with preserved ejection fraction (HFpEF): the phenotype-guided approach. Curr Treat Options Cardiovasc Med 21:20","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10121_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cardfail.2011.03.010","volume":"17","author":"D Abramov","year":"2011","unstructured":"Abramov D, He KL, Wang J, Burkhoff D, Maurer MS (2011) The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. J Card Fail 17:547\u2013555","journal-title":"J Card Fail"},{"key":"10121_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.147","volume":"16","author":"AB Santos","year":"2014","unstructured":"Santos AB, Kraigher-Krainer E, Gupta DK et al (2014) Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail 16:1096\u20131103","journal-title":"Eur J Heart Fail"},{"key":"10121_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","volume":"136","author":"M Obokata","year":"2017","unstructured":"Obokata M, Reddy YNV, Pislaru SV, Melenovsky V, Borlaug BA (2017) Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 136:6\u201319","journal-title":"Circulation"},{"key":"10121_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pcad.2006.08.007","volume":"49","author":"MS Maurer","year":"2006","unstructured":"Maurer MS, Kronzon I, Burkhoff D (2006) Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements. Prog Cardiovasc Dis 49:182\u2013195","journal-title":"Prog Cardiovasc Dis"},{"key":"10121_CR16","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","volume":"117","author":"D Westermann","year":"2008","unstructured":"Westermann D, Kasner M, Steendijk P et al (2008) Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117:2051\u20132060","journal-title":"Circulation"},{"key":"10121_CR17","first-page":"964","volume":"97","author":"BA Borlaug","year":"2011","unstructured":"Borlaug BA, Jaber WA, Ommen SR, Lam CSP, Redfield MM, Nishimura RA (2011) Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction 97:964\u2013969","journal-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction"},{"key":"10121_CR18","doi-asserted-by":"publisher","first-page":"e003612","DOI":"10.1161\/CIRCHEARTFAILURE.116.003612","volume":"10","author":"BA Borlaug","year":"2017","unstructured":"Borlaug BA, Carter RE, Melenovsky V et al (2017) Percutaneous pericardial resection: a novel potential treatment for heart failure with preserved ejection fraction. Circ Heart Fail 10:e003612","journal-title":"Circ Heart Fail"},{"key":"10121_CR19","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","volume":"296","author":"F Bursi","year":"2006","unstructured":"Bursi F, Weston SA, Redfield MM et al (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209\u20132216","journal-title":"JAMA"},{"key":"10121_CR20","first-page":"260","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS et al (2006) Outcome of heart failure with preserved ejection fraction in a population-based study 355:260\u2013269","journal-title":"Outcome of heart failure with preserved ejection fraction in a population-based study"},{"key":"10121_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMoa067758","volume":"357","author":"LW Miller","year":"2007","unstructured":"Miller LW, Pagani FD, Russell SD et al (2007) Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357:885\u2013896","journal-title":"N Engl J Med"},{"key":"10121_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.healun.2013.04.004","volume":"32","author":"MS Slaughter","year":"2013","unstructured":"Slaughter MS, Pagani FD, McGee EC et al (2013) HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 32:675\u2013683","journal-title":"J Heart Lung Transplant"},{"key":"10121_CR23","doi-asserted-by":"crossref","unstructured":"Mehra MR, Uriel N, Naka Y et al (2019) A fully magnetically levitated left ventricular assist device \u2014 final report. 380:1618\u20131627","DOI":"10.1056\/NEJMoa1900486"},{"key":"10121_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","volume":"345","author":"EA Rose","year":"2001","unstructured":"Rose EA, Gelijns AC, Moskowitz AJ et al (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435\u20131443","journal-title":"N Engl J Med"},{"key":"10121_CR25","doi-asserted-by":"publisher","first-page":"e004665","DOI":"10.1161\/CIRCHEARTFAILURE.117.004665","volume":"11","author":"L Sridharan","year":"2018","unstructured":"Sridharan L, Wayda B, Truby LK et al (2018) Mechanical circulatory support device utilization and heart transplant waitlist outcomes in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 11:e004665","journal-title":"Circ Heart Fail"},{"key":"10121_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jchf.2014.10.011","volume":"3","author":"D Burkhoff","year":"2015","unstructured":"Burkhoff D, Maurer MS, Joseph SM et al (2015) Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. JACC Heart Fail 3:275\u2013282","journal-title":"JACC Heart Fail"},{"key":"10121_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCHEARTFAILURE.110.959288","volume":"4","author":"Y Topilsky","year":"2011","unstructured":"Topilsky Y, Pereira NL, Shah DK et al (2011) Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 4:266\u2013275","journal-title":"Circ Heart Fail"},{"key":"10121_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/MAT.0b013e318286018d","volume":"59","author":"K Muthiah","year":"2013","unstructured":"Muthiah K, Phan J, Robson D et al (2013) Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series. Asaio j 59:183\u2013187","journal-title":"Asaio j"},{"key":"10121_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.healun.2015.03.012","volume":"34","author":"A Grupper","year":"2015","unstructured":"Grupper A, Park SJ, Pereira NL et al (2015) Role of ventricular assist therapy for patients with heart failure and restrictive physiology: improving outcomes for a lethal disease. J Heart Lung Transplant 34:1042\u20131049","journal-title":"J Heart Lung Transplant"},{"key":"10121_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.cardfail.2017.09.011","volume":"23","author":"SR Patel","year":"2017","unstructured":"Patel SR, Saeed O, Naftel D et al (2017) Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis. J Cardiac Fail 23:859\u2013867","journal-title":"J Cardiac Fail"},{"key":"10121_CR31","doi-asserted-by":"publisher","first-page":"e007931","DOI":"10.1161\/CIRCHEARTFAILURE.120.007931","volume":"13","author":"KC Michelis","year":"2020","unstructured":"Michelis KC, Zhong L, Tang WHW et al (2020) Durable mechanical circulatory support in patients with amyloid cardiomyopathy: insights from INTERMACS. Circ Heart Fail 13:e007931","journal-title":"Circ Heart Fail"},{"key":"10121_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","volume":"6","author":"CA Milano","year":"2018","unstructured":"Milano CA, Rogers JG, Tatooles AJ et al (2018) HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail 6:792\u2013802","journal-title":"JACC Heart Fail"},{"key":"10121_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jtcvs.2006.07.037","volume":"133","author":"D Morley","year":"2007","unstructured":"Morley D, Litwak K, Ferber P et al (2007) Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg 133:21\u201328","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10121_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jacc.2009.04.023","volume":"54","author":"B Meyns","year":"2009","unstructured":"Meyns B, Klotz S, Simon A et al (2009) Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol 54:79\u201386","journal-title":"J Am Coll Cardiol"},{"key":"10121_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ejcts.2010.07.049","volume":"39","author":"BP Meyns","year":"2011","unstructured":"Meyns BP, Simon A, Klotz S et al (2011) Clinical benefits of partial circulatory support in New York Heart Association class IIIB and early class IV patients. Eur J Cardiothorac Surg 39:693\u2013698","journal-title":"Eur J Cardiothorac Surg"},{"key":"10121_CR36","doi-asserted-by":"crossref","unstructured":"Fukamachi K, Horvath DJ, Karimov JH et al (2020) Left atrial assist device to treat patients with heart failure with preserved ejection fraction: initial in\u00a0vitro study. J Thorac Cardiovasc Surg","DOI":"10.1016\/j.jtcvs.2019.12.110"},{"key":"10121_CR37","doi-asserted-by":"crossref","unstructured":"Burkhoff D (2020) Commentary: Pumps for pEF. J Thorac Cardiovasc Surg","DOI":"10.1016\/j.jtcvs.2020.01.070"},{"key":"10121_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","volume":"387","author":"WT Abraham","year":"2016","unstructured":"Abraham WT, Stevenson LW, Bourge RC, Lindenfeld JA, Bauman JG, Adamson PB (2016) Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Lancet 387:453\u2013461","journal-title":"Lancet"},{"key":"10121_CR39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","volume":"387","author":"G Hasenfu\u00df","year":"2016","unstructured":"Hasenfu\u00df G, Hayward C, Burkhoff D et al (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 387:1298\u20131304","journal-title":"Lancet"},{"key":"10121_CR40","doi-asserted-by":"publisher","first-page":"e003662","DOI":"10.1161\/CIRCHEARTFAILURE.116.003662","volume":"9","author":"DM Kaye","year":"2016","unstructured":"Kaye DM, Hasenfu\u00df G, Neuzil P et al (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circ Heart Fail 9:e003662","journal-title":"Circ Heart Fail"},{"key":"10121_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.117.032094","volume":"137","author":"T Feldman","year":"2018","unstructured":"Feldman T, Mauri L, Kahwash R et al (2018) Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): a phase 2, randomized, sham-controlled trial. Circulation 137:364\u2013375","journal-title":"Circulation"},{"key":"10121_CR42","doi-asserted-by":"crossref","unstructured":"Rod\u00e9s-Cabau J, Bernier M, Amat-Santos IJ et al (2018) Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-Wave System. JACC: Cardiovascular Interventions. 11:2300\u20132310","DOI":"10.1016\/j.jcin.2018.07.001"},{"key":"10121_CR43","unstructured":"Snowden T (2012) Reversing heart failure: diastolic recoil in a proposed cardiac support device"},{"key":"10121_CR44","doi-asserted-by":"crossref","unstructured":"TCT-481: (2011) Diastolic heart failure \u2013 innovative extra and intra ventricular solutions. J Am Coll Cardiol. 58:B131","DOI":"10.1016\/j.jacc.2011.10.492"},{"key":"10121_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/eurjhf\/hfs150","volume":"15","author":"G Laurent","year":"2013","unstructured":"Laurent G, Eicher JC, Mathe A et al (2013) Permanent left atrial pacing therapy may improve symptoms in heart failure patients with preserved ejection fraction and atrial dyssynchrony: a pilot study prior to a national clinical research programme. Eur J Heart Fail 15:85\u201393","journal-title":"Eur J Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10121-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:51:56Z","timestamp":1620780716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10121-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":45,"alternative-id":["10121"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10121-w","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"3 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Burkhoff is a consultant to VADovation and CardioDyme.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}